BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38082206)

  • 21. Treatment patterns and health care costs among patients with psoriatic arthritis treated with biologic or targeted synthetic disease-modifying antirheumatic drugs.
    Murage MJ; Princic N; Park J; Malatestinic WN; Zhu B; Atiya B; Kern SA; Stenger KB; Sprabery AT; Ogdie A
    J Manag Care Spec Pharm; 2022 Feb; 28(2):206-217. PubMed ID: 35098751
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis.
    Jin Y; Lee H; Lee MP; Landon JE; Merola JF; Desai RJ; Kim SC
    Arthritis Care Res (Hoboken); 2022 Nov; 74(11):1792-1805. PubMed ID: 33973371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.
    Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
    Arthritis Rheumatol; 2014 May; 66(5):1282-90. PubMed ID: 24782185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Rodgers M; Epstein D; Bojke L; Yang H; Craig D; Fonseca T; Myers L; Bruce I; Chalmers R; Bujkiewicz S; Lai M; Cooper N; Abrams K; Spiegelhalter D; Sutton A; Sculpher M; Woolacott N
    Health Technol Assess; 2011 Feb; 15(10):i-xxi, 1-329. PubMed ID: 21333232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database.
    Pina Vegas L; Penso L; Claudepierre P; Sbidian E
    JAMA Dermatol; 2022 May; 158(5):513-522. PubMed ID: 35319735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study.
    Tillett W; Ogdie A; Passey A; Gorecki P
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36650006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of Psoriatic Arthritis Among Patients Receiving Biologic Treatments for Psoriasis: A Nested Case-Control Study.
    Rosenthal YS; Schwartz N; Sagy I; Pavlovsky L
    Arthritis Rheumatol; 2022 Feb; 74(2):237-243. PubMed ID: 34423909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis.
    Stober C; Ye W; Guruparan T; Htut E; Clunie G; Jadon D
    Rheumatology (Oxford); 2018 Jan; 57(1):158-163. PubMed ID: 29077973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of uveitis in patients with psoriatic arthritis.
    Paiva ES; Macaluso DC; Edwards A; Rosenbaum JT
    Ann Rheum Dis; 2000 Jan; 59(1):67-70. PubMed ID: 10627431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic delay is associated with uveitis and inflammatory bowel disease in AS: a study of extra-musculoskeletal manifestations in SpA.
    Michelena X; Zhao SS; Marco-Pascual C; Almirall M; Collantes-Estevez E; Font-Ugalde P; López-Medina C; Wei JC; Morgan AW; Rodríguez J; Juanola X; Vázquez-Mellado J; Marzo-Ortega H
    Rheumatology (Oxford); 2024 Feb; 63(2):430-435. PubMed ID: 37184889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.
    Ogdie A; Yu Y; Haynes K; Love TJ; Maliha S; Jiang Y; Troxel AB; Hennessy S; Kimmel SE; Margolis DJ; Choi H; Mehta NN; Gelfand JM
    Ann Rheum Dis; 2015 Feb; 74(2):326-32. PubMed ID: 25351522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragility fractures in psoriatic arthritis patients: a matched retrospective cohort study.
    Lo Giudice LF; Scolnik M; Pierini FS; Marin Zucaro NM; Jaramillo Gallego JF; Soriano ER
    Clin Rheumatol; 2020 Dec; 39(12):3685-3691. PubMed ID: 32462424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.
    Zhu B; Edson-Heredia E; Gatz JL; Guo J; Shuler CL
    Clin Ther; 2013 Sep; 35(9):1376-85. PubMed ID: 23954091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Patients With Psoriatic Arthritis Compared to Patients Without Psoriatic Arthritis.
    Li L; Hagberg KW; Peng M; Shah K; Paris M; Jick S
    J Clin Rheumatol; 2015 Dec; 21(8):405-10. PubMed ID: 26406567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database.
    Di Minno MN; Iervolino S; Zincarelli C; Lupoli R; Ambrosino P; Pizzicato P; Di Minno A; Pappone N; Peluso R
    Expert Opin Drug Saf; 2015; 14(12):1905-13. PubMed ID: 26618553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of psoriasis in patients with uveitis: A nationwide population-based cohort study.
    Chen YY; Chen HH; Lo TC; Chou P
    PLoS One; 2021; 16(8):e0255492. PubMed ID: 34339476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study.
    Kougkas N; Magiouf K; Gialouri CG; Evangelatos G; Pappa M; Dimouli A; Iliopoulos A; Karmanakos A; Dimitroulas T; Tektonidou MG; Sfikakis PP; Fragoulis GE
    Rheumatol Int; 2023 Nov; 43(11):2081-2088. PubMed ID: 37610650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study.
    Egeberg A; Khalid U; Gislason GH; Mallbris L; Skov L; Hansen PR
    JAMA Dermatol; 2015 Nov; 151(11):1200-5. PubMed ID: 26222707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association of Psoriatic Arthritis With All-cause Mortality and Leading Causes of Death in Psoriatic Arthritis.
    Haddad A; Saliba W; Lavi I; Batheesh A; Kasem S; Gazitt T; Feldhamer I; Cohen AD; Zisman D
    J Rheumatol; 2022 Feb; 49(2):165-170. PubMed ID: 34266988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries.
    Egeberg A; Rosenø NAL; Aagaard D; Lørup EH; Nielsen ML; Nymand L; Kristensen LE; Thyssen JP; Thomsen SF; Cordtz RL; Loft N; Skov L; Bryld LE; Rasmussen MK; Højgaard P; Kristensen S; Dreyer L
    Semin Arthritis Rheum; 2022 Apr; 53():151979. PubMed ID: 35183936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.